Endocrine Gland Neoplasms
Information
- Disease name
- Endocrine Gland Neoplasms
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00050414 | Completed | Phase 2 | A Study of Trabectedin in Patients With Advanced Ovarian Cancer | October 2002 | September 2005 |
| NCT01964430 | Completed | Phase 3 | Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the "Apact" Study) | March 28, 2014 | June 30, 2022 |
| NCT02897778 | Completed | Phase 1 | Cardiac Safety Study of Entinostat in Men and Women With Advanced Solid Tumors | August 24, 2016 | March 13, 2017 |
| NCT02909452 | Completed | Phase 1 | Continuation Study of Entinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumors | September 20, 2016 | February 9, 2021 |
| NCT03535727 | Completed | Phase 1/Phase 2 | A Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan in Metastatic Pancreatic Cancer | June 21, 2018 | October 3, 2022 |
| NCT03717298 | Completed | Phase 2 | Evaluation of Ocoxin-Viusid® in Advanced Pancreatic Adenocarcinoma | October 30, 2018 | January 20, 2023 |
| NCT05022667 | Recruiting | N/A | Assessing Benefits of Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Total Thyroidectomy | December 1, 2021 | August 2024 |
| NCT01763125 | Recruiting | Establishment of a Tumor Bank for Blood Samples | November 2003 | December 2026 | |
| NCT01789229 | Recruiting | Establishment of a Tumor Bank for Tissue Samples | September 2003 | December 2026 | |
| NCT05152927 | Recruiting | N/A | Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Parathyroidectomy | January 10, 2022 | January 31, 2025 |
| NCT04949282 | Recruiting | Spanish Series of Patients Treated With the Radionuclide Lutetium177 | May 10, 2021 | December 31, 2035 | |
| NCT04556071 | Unknown status | Phase 2 | Efficacy and Safety of Niraparib Combined With Bevacizumab in Platinum Refractory/Resistant Recurrent Ovarian Cancer | November 6, 2020 | October 1, 2022 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D004701